StreetAlpha.app
Home › Stocks › SCNX

Scienture Holdings, Inc. (SCNX)

$2.28
▼ −6.45%
LAST CLOSE · NOV 20

Scienture is a pharmaceutical company that markets and develops prescription medicines for heart and nervous system diseases. It last closed at $2.28 on Nov 20, down 6.45% on the day. The next earnings report for SCNX is expected around Thu, Feb 18, 2027, after the close. For the quarter ended Sep 2026, SCNX reported EPS of -$3.76 on revenue of $1.3M, with revenue up 112.6% from a year ago. Over its last 8 reports the stock moved an average of 8.4% the session after earnings.

AI Auto Pilots
Is SCNX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SCNX.

Key Stats

Last 12 months
Results
Revenue
$1.5M
+127.4% vs a year ago
Net income
−$40.4M
−2715.9% margin
Gross margin
78.5%
$1.2M gross profit
Operating margin
−2788.5%
−$41.4M operating income
Valuation
Market cap
$4.1M
1.8M shares
P/E
–
Price to sales
2.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$4.7M
At Sep 30
Shareholder equity
$58.7M
Shares outstanding
1.8M
At Nov 13
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $9.9M$9.9MFY2021FY2022: $10.3M$10.3MFY2022FY2023: $1.4M$1.4MFY2023FY2024: $137K$137KFY2024FY2025: $432K$432KFY2025

From SCNX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Next report
Feb 18
Estimated date · After the close
Reported EPS
-$3.76
Quarter ended Sep 2026
Year ago EPS
-$4.76
Same quarter last year
Revenue
$1.3M
+112.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$6.11Dec '24Mar 2025: -$0.33Mar '25Jun 2025: -$0.48Jun '25Sep 2025: -$4.76Sep '25Dec 2025: $20.76Dec '25Mar 2026: -$0.08Mar '26Jun 2026: -$0.07Jun '26Sep 2026: -$3.76Sep '26Latest -$3.76
Revenue by quarter
Dec 2024: $53,083Dec '24Mar 2025: $10,258Mar '25Jun 2025: $0Jun '25Sep 2025: $590,050Sep '25Mar 2026: $56,325Mar '26Jun 2026: $343,639Jun '26Sep 2026: $1.3MSep '26Latest $1.3M
How SCNX moved after its last 8 reports
Average move the session after a report ±8.4%
Nov 19, 2026After the close−6.5%
Oct 19, 2026After the close+4.5%
Aug 20, 2026After the close−4.7%
May 22, 2026After the close−0.5%
May 15, 2023After the close−16.3%
Mar 27, 2023After the close−20.8%
Nov 7, 2022After the close−6.9%
Jul 25, 2022After the close−6.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on SCNXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SCNX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SCNX

Technical Analysis

SCNX · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 33% below its 20 day and 90% below its 50 day average. It is 273% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 24), oversold. The nearest support is the Pivot at $2.22, and the nearest resistance the Pivot R1 at $2.43.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 16.5%/day
Key levels
$18.7552 week high+722.4%
$8.50200 day average+272.8%
$7.07100 day average+210.1%
$4.3450 day average+90.4%
$3.27Swing high (Nov 16)+43.4%
$3.0420 day average+33.3%
$2.43Pivot R1+6.6%
$2.28Last close
$2.22Pivot−2.6%
$2.06Pivot S1−9.6%
$2.0052 week low−12.3%
Indicators
RSI (14)24.26Oversold below 30Oversold
MACD-0.49Above its signal lineBullish
Stochastic18.3Near the bottom of its rangeOversold
ADX (14)38.8Trending down
Williams %R-81.1Oversold below −80, overbought above −20Oversold
CCI (20)-245.3Oversold below −100, overbought above 100Oversold
Rate of change−27.1%Change over 10 sessionsBearish
ATR (14)$0.38Typical daily range, 16.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SCNX

What happened before

See how SCNX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SCNX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SCNX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SCNXHow many large options trades hit SCNX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

SCNX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼4 buying vs 9 selling
  • ▲Held by funds +3.7 pts
  • ▼Funds holding -2
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1416−12.5%
In funds' top 1000–
Held by funds117.1%113.3%+3.7 pts
New / increased2 / 24 / 5−55.6%
Reduced / sold out5 / 44 / 2+50.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SCNX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SCNX is in one of them and how their past SCNX trades turned out.

SCNX in the AI portfolios
Loading…

SCNX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SCNX in an article yet. Here's the latest on the wider market.

SCNX in the news

About Scienture Holdings

Scienture is a specialty pharmaceutical company based in Commack, New York. It markets and develops prescription medicines for cardiovascular and central nervous system conditions, serving patients in the United States. Its marketed products include an oral liquid form of losartan for high blood pressure and a nasal spray naloxone product for opioid overdose. The company also has a pipeline of candidate treatments for conditions such as migraine, blood clots, and pain.

Headquarters
Commack, NY